Ozempic or Bust
America has been trying to address the obesity epidemic for four decades now. So far, each new “solution” has failed to live up to its early promise.
America has been trying to address the obesity epidemic for four decades now. So far, each new “solution” has failed to live up to its early promise.
George and Lori Schappell didn’t seem to care whether others understood them. But America is still struggling to accommodate bodies like theirs.
Can humans ever break free of menopause?
The diagnosis is officially gone, but health anxiety is everywhere.
Medieval people had a lot of leprosy. So did their pet squirrels.
Rescheduling weed will clear the way for scientists to study it more directly.
The bird-flu panic is getting out of hand.
But are they really such a good idea?
Somehow, the U.S. is both over- and under-reacting to bird flu and other pressing infectious threats.
To access the full benefits of literature, you have to share it out loud.
Unfortunately, it’s still nothing like real sugar.
Finding a matched donor has always been the major challenge. A drug has solved that problem.
They could benefit from a diversity of hormones, empathy about their experience, and a frank approach to sexuality—all hallmarks of trans health care.
The long-term effects of GLP-1 drugs are unknown.
The cocoa shortage is making chocolate more expensive—maybe forever.
No one can decide on the drinking age for “adult” drinks that don’t contain alcohol.
Will legal psychedelics be any better?
An abundance of new methods for men could transform women’s contraception too.
More physicians are making gun safety part of routine visits. But should they be?
Nicotine has been on a long journey to become candy.